/BCYP
BCYP Stock - Big Cypress Acquisition Corp.
Healthcare|BiotechnologyNASDAQ
$8.44-19.23%
$2.01 (-19.23%) • Oct 25
64
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.52
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.80
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $9.28
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for BCYP
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$8.36 – $8.52
TARGET (TP)$9.71
STOP LOSS$7.76
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.00
52W High$12.90
52W Low$7.30
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2020 | FY2019 |
|---|---|---|---|
| Revenue | $1.32M | N/A | $3.44M |
| Gross Profit | N/A | N/A | $3.44M |
| Gross Margin | 0.0% | N/A | 100.0% |
| Operating Income | $-42,910,520 | N/A | $-8,673,540 |
| Net Income | $-34,105,309 | N/A | $-8,986,289 |
| Net Margin | -2579.0% | N/A | -261.1% |
| EPS | $-3.68 | $0.00 | $-0.21 |
Company Overview
Big Cypress Acquisition Corp. intends to acquire assets and businesses through a merger, capital stock exchange, stock purchase, reorganization, or similar business combination. It intends to focus on life science companies in the United States and Israel. The company was founded in 2020 and is based in Miami Beach, Florida.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
BCYPLoading earnings data...
Latest News
Loading news...
Frequently Asked Questions about BCYP
What is BCYP's current stock price?
Big Cypress Acquisition Corp. (BCYP) is currently trading at $8.44 per share. The stock has moved -19.23% today.
What is the analyst price target for BCYP?
No analyst price targets are currently available for this stock.
What sector is Big Cypress Acquisition Corp. in?
Big Cypress Acquisition Corp. operates in the Healthcare sector, specifically within the Biotechnology industry. The company is traded on the NASDAQ exchange.
What is BCYP's market cap?
Big Cypress Acquisition Corp. has a market capitalization of $0.43 billion, making it a small-cap company.
Does BCYP pay dividends?
No, Big Cypress Acquisition Corp. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorCKPT
Checkpoint Therapeutics, Inc.
$4.26
Mkt Cap: $0.4B
CLYM
Climb Bio, Inc.
$4.28
Mkt Cap: $0.3B
GTHX
G1 Therapeutics, Inc.
$7.16
Mkt Cap: $0.4B
ITOS
iTeos Therapeutics, Inc.
$10.15
Mkt Cap: $0.4B
IVVD
Invivyd, Inc.
$2.30
Mkt Cap: $0.3B
ORTX
Orchard Therapeutics plc
$16.70
Mkt Cap: $0.4B
RVNC
Revance Therapeutics, Inc.
$3.65
Mkt Cap: $0.4B
SVA
Sinovac Biotech Ltd.
$6.47
Mkt Cap: $0.5B
VIGL
Vigil Neuroscience, Inc.
$8.05
Mkt Cap: $0.4B
YMAB
Y-mAbs Therapeutics, Inc.
$8.61
Mkt Cap: $0.4B
Explore stocks similar to BCYP for comparison